Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04865250
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2021-03-08
Brief Title:
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus CarboplatinNab Paclitaxel in Resectable Non-squamous NSCLC
Sponsor:
Organization:
University Hospital Heidelberg